Chronic herniated disc pain doesn't make spinal fusion your only option. Learn how biologic disc repair — intra-annular fibrin injection — may help many patients find lasting relief without surgery, and how candidacy is determined.

Lumbar fusion is not the only path for chronic back pain. Regenerative treatments like intra-annular fibrin injection may help many patients by targeting annular tears and supporting natural disc repair — without permanent hardware. Candidacy varies; our clinical team evaluates each case individually.

Intra-annular fibrin injection is a biologic disc repair procedure that targets annular tears at their structural source. For candidates with chronic discogenic pain, it may offer a non-surgical alternative to fusion; outcomes vary by individual case and diagnostic profile.

Intra-annular fibrin injection and traditional discectomy take different approaches to disc-related back pain. Learn how each works, who may qualify, and what to weigh when evaluating your treatment options.

For many patients diagnosed with spinal instability, spinal fusion is not the only path forward. Non-surgical approaches — including biologic disc repair and targeted regenerative treatments — may help reduce pain and improve stability in appropriate candidates. Outcomes vary, and individual evaluation determines the right fit.

Spinal injections and intra-annular fibrin injection address chronic disc pain through fundamentally different mechanisms. Learn how they compare and how candidacy is evaluated at Valor Spine.

Intra-annular fibrin injection targets annular tears — a structural root cause of chronic discogenic back pain — through a minimally invasive outpatient procedure. For patients who meet candidacy criteria and have not found lasting relief through conservative care, this biologic disc repair approach may offer a non-surgical path to pain reduction and disc healing.